Cite Filings / IMDX
Feed Companies Filings Check
Sign in

CIK 0001642380

  • Non-accelerated filer
  • Smaller reporting company

Insight Molecular Diagnostics Inc.

Sign in to watch
Ticker
IMDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
271041563
Phone
+1 949-409-7600
Business address
2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
Former names
OncoCyte Corp, Oncocyte Corp
Filings Financials Insiders Search text
All 688 Financials 234 Shareholder Meetings 19 Executive Compensation 215 Insider Trading 257 Beneficial Ownership Interest 64 Business Combinations 184 Public Offerings 68 Mutual Funds and ETFs 13 Others 59
›
Filed in
  1. No filings match these filters. Clear filters
  2. S-1/A Offering Registration Statement 2016-10-18
  3. UPLOAD Other SEC-generated Letter 2016-10-11
  4. S-1 Offering Registration Statement 2016-09-26
  5. UPLOAD Other SEC-generated Letter 2015-12-29
  6. CORRESP Other Correspondence Between Filers and SEC Staff 2015-12-28
  7. CORRESP Other Correspondence Between Filers and SEC Staff 2015-12-28
  8. UPLOAD Other SEC-generated Letter 2015-12-15
  9. UPLOAD Other SEC-generated Letter 2015-11-05

Page 4 of 4 · 68 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…